Information about Doca-Pharma
My details
*
*
*

Doca-Pharma (SRL)

BE

1013.386.219

Company information

Status
Active

Enterprise number

BE1013.386.219

VAT liability
Yes
Established
10-09-2024
Last balance sheet year
2025
Company size
Micro 0,6 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Doca-Pharma

2025 2024
Income statement
Profit/Loss € -64,546 -219% € -20,208
Gross margin € -27,380 -46% € -18,752
Balance sheet
Balance sheet total € 72,384 -19% € 89,282
Equity € -79,753 -424% € -15,208
Debts € 152,137 46% € 104,490
Other
Employees 0.6

Publications from Doca-Pharma

Date Publication
12-09-2024 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Doca-Pharma?
The VAT number of Doca-Pharma is BE 1013.386.219.
Wat is the PEPPOL ID of Doca-Pharma?
The PEPPOL ID of Doca-Pharma is 0208:1013386219. Log in or start a free trial to see the full overview.
When was Doca-Pharma founded?
Doca-Pharma was founded on 10-09-2024.
What is the address of Doca-Pharma?
The current registered office of Doca-Pharma is located at Edgar Tinelstraat 11, 9112 Sint-Niklaas.
When was the last time Doca-Pharma filed their annual financial statements?
The most recent financial statements of Doca-Pharma were filed on 24-07-2026.
How many employees does Doca-Pharma have?
There are 0,6 FTEs working at Doca-Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Doca-Pharma?
At the time of its most recent financial statements, Doca-Pharma did not publish any turnover figures. Doca-Pharma reported a gross margin of -€27,379.69.

Sources